XyloCor Therapeutics is a development-stage, biotechnology company dedicated to developing first-in-class gene therapies for patients with unmet medical need in cardiovascular disease.

Research

XyloCor Therapeutics

XyloCor Therapeutics' headquarters in Malvern, PA, United States

Albert Gianchetti

Rémi Gloeckler

A. Brian Davis

Howard Dittrich

Ronald Crystal

Todd Rosengart

Alan Colowick

Nikhil Thatte

Lizzie Ngo

Aidan King

John de Koning

Daniel Hetu

Glenn Batchelder

Fouad Azzam

The Advisory and Governance team at XyloCor Therapeutics provides strategic oversight and expert guidance in the development of innovative gene therapies for cardiovascular diseases. Comprised of seasoned professionals with diverse backgrounds in medicine, biotechnology, and business leadership, the team ensures sound decision-making, regulatory compliance, and alignment with the company's mission to address significant patient needs. Their collective expertise drives both the research and operational strategies essential for advancing the company's therapeutic pipeline.

Advisory and Governance

The Leadership Team at XyloCor Therapeutics is responsible for setting the strategic direction and vision of the company, guiding the development of innovative gene therapies for cardiovascular diseases. This dynamic team, comprising executives from critical areas such as technology, manufacturing, clinical operations, and medicine, collaborates to align scientific advancements with regulatory requirements and market opportunities, ensuring the successful advancement of projects from concept to clinical application.

Leadership Team

XyloCor Therapeutics

Org chart

Board & advisors

Teams

Advisory and Governance

Leadership Team

Offices

XyloCor Therapeutics

Org chart

Board & advisors

Teams

Advisory and Governance

Leadership Team

Offices

Related companies